港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

432.705

-14.664-3.28%

漲家數：6

跌家數：24

平家數：3

市盈率：- -

高：446.899

開：446.899

低：429.612

收：447.369

成交量：5,337.17萬

成交額：13.25億

市值：2,789.27億

流通市值：2,486.06億

資料載入中...

總覽新聞資訊

翰森製藥(03692)已上市創新藥所有獲批適應症均已納入醫保目錄

藥明巨諾-B(02126.HK)：倍諾達® (瑞基奧侖賽注射液)納入國家基本醫保藥品目錄

遠大醫藥(00512)六款產品成功納入 2026 年國家醫保藥品目錄、商保創新藥目錄及行業配套清單

遠大醫藥(00512.HK)六款產品成功納入 2026 年國家醫保藥品目錄、商保創新藥目錄及行業配套清單

華東醫藥(000963.SZ)：產品及合作產品納入國家醫保目錄及商保創新藥目錄

諾誠健華(688428.SH)：佐來曲替尼片納入2026年國家醫保目錄

諾誠健華：佐來曲替尼納入2026年國家醫保目錄

重磅創新藥進入醫保！復星醫藥6款藥品迎來醫保身份升級，覆蓋首次納入、適應症擴容

深圳商报·读创

A股多家醫藥企業集中披露，公司旗下藥品納入國家醫藥目錄

百萬CAR-T進醫保之後：商保轉基本醫保通道打開，放量驗證才剛開始

醫保目錄擴容背後：創新藥准入的閘門正在換一種開法

商保藥品推薦清單如何推動高價創新藥可及性？行業人士解讀

每日经济新闻

創新藥數量創新高！百萬元一針的CAR-T首次納入，新版醫保藥品目錄有哪些變化？

每日经济新闻

腦卒中創新藥先必新®舌下片首次納入基本醫保目錄

2026年版國家醫保藥品目錄公布：51個1類新藥、首例CAR-T入保、「預申報」落地

擊穿百萬價格後，首批轉目錄的創新藥銷量能大爆發嗎？

新聞周刊丨創新藥進院難在哪？如何打通「最後一公里」？

商保創新藥目錄擴容至28種：如何讓更多患者用上高價創新藥？

每日经济新闻

新版醫保目錄新增51個一類新藥，CAR-T首進，還有哪些亮點？

亞盛醫藥利生妥®成功納入2026年國家醫保藥品目錄，耐立克®續約

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/BK1574/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":432.7054,"timestamp":1794557295263,"preClose":447.36902,"halted":0,"volume":53371670,"delay":0,"changeRate":-0.032777,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-14.663605,"latestTime":"11-13 16:00:00","open":446.8992,"high":446.8992,"low":429.61166,"amount":1325489079.5,"amplitude":0.038643,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1794792600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1794533400000,1794542400000],[1794546000000,1794556800000]],"pbRate":3.191364,"peRate":89.597205,"turnoverRate":0.001985,"increases":7,"decrements":24,"flats":1,"marketCap":278927212400,"floatMarketCap":248606026976},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":446.8992,"amplitude":0.038643,"preClose":447.36902,"low":429.61166,"pbRate":"3.191364","latestPrice":432.7054,"volume":53371670,"delay":0,"open":446.8992,"prevYearClose":556.26263,"prevWeekClose":441.249,"prevMonthClose":422.244,"prevQuarterClose":532.388,"fiveDayClose":441.249,"twentyDayClose":455.098,"sixtyDayClose":492.831,"secType":"PLATE","market":"HK","turnoverRate":0.001985,"peRate":89.597205,"marketCap":278927212400,"floatMarketCap":248606026976,"timestamp":1794557295263,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":6,"down":24,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2683659954","title":"翰森製藥(03692)已上市創新藥所有獲批適應症均已納入醫保目錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2683659954","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683659954?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 18:45","pubTimestamp":1794739531,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药 公布，集团创新药阿美乐新增一项适应症、昕越新增两项适应症成功纳入新版《国家基本医疗保险、工伤保险和生育保险药品目录》，新版国家目录将于2027年1月1日正式实施。集团已上市创新药所有获批适应症均已纳入医保目录，有助于进一步提高各创新药在患者中的可负担性和可及性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","BK1161","MEDX","IBBQ","IPOS","BK1191","BK1583","BK1574","03692","06978","LNGR","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683659314","title":"藥明巨諾-B(02126.HK)：倍諾達® (瑞基奧侖賽注射液)納入國家基本醫保藥品目錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2683659314","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683659314?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 18:25","pubTimestamp":1794738305,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","BK1574","BK1161","02126"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683855659","title":"遠大醫藥(00512)六款產品成功納入 2026 年國家醫保藥品目錄、商保創新藥目錄及行業配套清單","url":"https://stock-news.laohu8.com/highlight/detail?id=2683855659","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683855659?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 18:09","pubTimestamp":1794737396,"startTime":"0","endTime":"0","summary":"智通财经APP讯，远大医药 公布，近日，集团共有六款产品成功纳入由中华人民共和国国家医疗保障局发布的《国家基本医疗保险、生育保险和工伤保险药品目录》 《商业健康保险创新药品目录》、中国保险行业协会发布的《商业健康保险药品保障推荐清单(第一版)》或中国精算师协会发布的《商业健康保险保障成本测算涉及药品》。集团相信，医保与商保的协同联动，是国家“保基本、促创新”、大力支援创新药高质量发展的重要举措。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523317.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","159992","BK1191","BK1574","MEDX","00512","LNGR","06978","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683665985","title":"遠大醫藥(00512.HK)六款產品成功納入 2026 年國家醫保藥品目錄、商保創新藥目錄及行業配套清單","url":"https://stock-news.laohu8.com/highlight/detail?id=2683665985","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683665985?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 18:09","pubTimestamp":1794737396,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00512","BK1191","BK1161","06978","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683656765","title":"華東醫藥(000963.SZ)：產品及合作產品納入國家醫保目錄及商保創新藥目錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2683656765","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683656765?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 17:49","pubTimestamp":1794736167,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华东医药(000963.SZ)发布公告，公司部分产品及合作产品被纳入新版药品目录及新版商保创新药目录。公司全资子公司杭州中美华东制药有限公司马来酸美凡厄替尼片被纳入协议期内谈判药品部分;合作产品脯氨酸加格列净片完成续约，支付标准与支付范围不变;他克莫司颗粒调整至常规目录管理，支付范围较前一版药品目录没有变动;合作产品泽沃基奥仑赛注射液继续被纳入新版商保创新药目录。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523313.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0209","BK1161","BK0175","BK0187","000963","159992","BK0183","BK0132","IBBQ","LU1969619763.USD","LU2328871848.SGD","BK0196","BK0188","BK1574","MEDX","06978","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683566666","title":"諾誠健華(688428.SH)：佐來曲替尼片納入2026年國家醫保目錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2683566666","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683566666?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 17:03","pubTimestamp":1794733381,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺诚健华(688428.SH)发布公告，公司自主研发的新一代TRK抑制剂佐来曲替尼片(商品名：宜诺欣®)被纳入新版国家医保目录，用于治疗携带NTRK融合基因的成人和12岁以上青少年实体瘤患者。新版国家医保目录将自2027年1月1日起正式实施。协议有效期为2027年1月1日至2028年12月31日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1523306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1161","BK1574","688428","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683656366","title":"諾誠健華：佐來曲替尼納入2026年國家醫保目錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2683656366","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683656366?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 16:53","pubTimestamp":1794732816,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["09969","BK1574","688428","BK1161","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683656266","title":"重磅創新藥進入醫保！復星醫藥6款藥品迎來醫保身份升級，覆蓋首次納入、適應症擴容","url":"https://stock-news.laohu8.com/highlight/detail?id=2683656266","media":"深圳商报·读创","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683656266?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 16:40","pubTimestamp":1794732053,"startTime":"0","endTime":"0","summary":"深圳商报·读创客户端记者穆砚11月15日，上海复星医药（集团）股份有限公司（以下简称“复星医药”或“公司”）发布关于控股子公司药品获新纳入国家医保目录的提示性公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611153931459076.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611153931459076.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","BK0060","02196","600196","BK1574","BK0183","BK1515","BK0012","159992","BK1191","BK1593","LNGR","BK0196","BK1161","BK0187","MEDX","IBBQ","BK0175","BK0028","BK0188","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683656116","title":"A股多家醫藥企業集中披露，公司旗下藥品納入國家醫藥目錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2683656116","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683656116?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 16:37","pubTimestamp":1794731846,"startTime":"0","endTime":"0","summary":"15日，多家A股上市医药企业公告称，公司相关药品续约或纳入2026年版国家医保目录。微芯生物公告称，公司产品西格列他钠片（双洛平?）成功续约《国家医保目录》，药品分类为乙类，协议有效期为2027年1月1日至2028年12月31日。西格列他钠是公司独家发现的全球首个获批上市的PPAR全激动剂，用于治疗2型糖尿病，2023年首次纳入国家医保目录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611153931457172.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611153931457172.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02827","BK1161","03188","BK1515","83188","02843","82823","82843","159982","07233","BK1574","09939","02823","BK1610","BK1147","02822","159938","83130","03130","82822","02846","399300","82846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683656838","title":"百萬CAR-T進醫保之後：商保轉基本醫保通道打開，放量驗證才剛開始","url":"https://stock-news.laohu8.com/highlight/detail?id=2683656838","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683656838?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 16:26","pubTimestamp":1794731160,"startTime":"0","endTime":"0","summary":"药明巨诺的瑞基奥仑赛注射液进入基本医保目录的消息，让一位资深医药人士在11月14日难掩激动。他的判断很直接：这款CAR-T细胞药物明年销量会大涨。瑞基奥仑赛由此成为继诺西那生钠之后，又 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261115/c681829667.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261115/c681829667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK1161","MEDX","06978","LNGR","BK1574","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683656833","title":"醫保目錄擴容背後：創新藥准入的閘門正在換一種開法","url":"https://stock-news.laohu8.com/highlight/detail?id=2683656833","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683656833?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 16:24","pubTimestamp":1794731040,"startTime":"0","endTime":"0","summary":"11月14日，2026年国家医保药品目录与商业健康保险创新药品目录在苏州公布。新版基本医保目录新增107种药品，其中1类创新药51个，数量创历史新高；目录药品总数达到3331个，西药1935个、中成 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261115/c681829671.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261115/c681829671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["LNGR","BK1161","159992","06978","IBBQ","BK1574","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683165533","title":"商保藥品推薦清單如何推動高價創新藥可及性？行業人士解讀","url":"https://stock-news.laohu8.com/highlight/detail?id=2683165533","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683165533?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 15:07","pubTimestamp":1794726452,"startTime":"0","endTime":"0","summary":"近日，中国保险行业协会（以下简称中保协）正式发布三份商业医疗保险示范条款及《商业健康保险药品保障推荐清单（第一版）》（下称“商保药品推荐清单”）。其中，商保药品推荐清单作为医疗险示范条款的重要组成部分，适用于院外特定药械责任，与短期、长期两款一般商业医疗保险示范条款配套使用。长期以来，创新药商业化面临“基本医保门槛高、商业保险量太小”的双重困境。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://insurance.eastmoney.com/a/202611153931422724.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://insurance.eastmoney.com/a/202611153931422724.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","MEDX","IBBQ","LNGR","BK1161","BK1574","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683653204","title":"創新藥數量創新高！百萬元一針的CAR-T首次納入，新版醫保藥品目錄有哪些變化？","url":"https://stock-news.laohu8.com/highlight/detail?id=2683653204","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683653204?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 14:37","pubTimestamp":1794724636,"startTime":"0","endTime":"0","summary":"11月14日，2026年创新药高质量发展大会在苏州金鸡湖国际会议中心召开。《每日经济新闻》记者（以下简称每经记者）在现场获悉，2026年《国家基本医疗保险、生育保险和工伤保险药品目录》（以下简称“医保目录”）以及《商业健康保险创新药品目录》（以下简称“商保创新药目录”）正式公布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611153931421676.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611153931421676.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","MEDX","IBBQ","BK1574","06978","LNGR","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683658492","title":"腦卒中創新藥先必新®舌下片首次納入基本醫保目錄","url":"https://stock-news.laohu8.com/highlight/detail?id=2683658492","media":"新浪科技","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683658492?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 12:57","pubTimestamp":1794718620,"startTime":"0","endTime":"0","summary":"脑卒中素有高发病、高致残的特点，其中急性缺血性卒中占全部卒中的85%以上。在临床应用场景上，先必新注射液与舌下片形成互补与接力。先必新注射液主要聚焦于医院内的急性期规范治疗，为院内抢救提供强有力的支持；而先必新舌下片则凭借独特的舌下速崩剂型，将治疗场景成功拓展到了出院与居家康复。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tech/shenji/2026-11-15/doc-iniyuuaf2103793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","159992","BK1161","LNGR","IBBQ","06978","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683637717","title":"2026年版國家醫保藥品目錄公布：51個1類新藥、首例CAR-T入保、「預申報」落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2683637717","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683637717?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 10:09","pubTimestamp":1794708581,"startTime":"0","endTime":"0","summary":"新版国家医保药品目录新增107种药品，其中51个一类新药，再创历史新高。此次调整后，2026年版国家医保药品目录药品总数达到3331个，其中西药1935个、中成药1396个。此外，商业健康保险创新药品目录同步调整，新增12种药品；调整后，2026年商业健康保险创新药品目录共有28种。两个目录将于2027年1月1日正式执行。2026年首次允许已完成技术审评、但尚未拿到正式批件的药品提前预申报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1794708540205267972","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LNGR","BK1574","IBBQ","MEDX","BK1161","06978","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683375086","title":"擊穿百萬價格後，首批轉目錄的創新藥銷量能大爆發嗎？","url":"https://stock-news.laohu8.com/highlight/detail?id=2683375086","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683375086?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 09:01","pubTimestamp":1794704460,"startTime":"0","endTime":"0","summary":"“创新药要爆发了，这款CAR-T明年销量会大涨！”这成为我国医保谈判历史上又一标志性事件，表明商保目录药品转入基本医保的通道正式打通。黄心宇表示，今年共有7个药品提出申请，最终成功2个。价格是高值创新药进入基本医保最重要的条件。国家医保局医药价格和招标采购指导中心主任丁一磊在政策解读活动中表示，医保准入是创新药商业化的关键放大器。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-11-15/doc-iniyupue9788616.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-11-15/doc-iniyupue9788616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","BK1574","IBBQ","MEDX","BK1161","06978","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683632828","title":"新聞周刊丨創新藥進院難在哪？如何打通「最後一公里」？","url":"https://stock-news.laohu8.com/highlight/detail?id=2683632828","media":"央视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683632828?lang=zh_tw&edition=fundamental","pubTime":"2026-11-15 01:54","pubTimestamp":1794678840,"startTime":"0","endTime":"0","summary":"长期以来，创新药即使进入医保，仍需经医院药事委员会审核等层层环节才能进入医院。本周二，国家卫健委等四部门联合印发《关于进一步做好创新药安全合理配备使用工作的通知》，提出要从四个方面直面这些体制机制障碍，为创新药第一时间抵达患者手中提速。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-11-15/doc-iniytwwr2437582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","MEDX","IBBQ","LNGR","BK1161","BK1574","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683636427","title":"商保創新藥目錄擴容至28種：如何讓更多患者用上高價創新藥？","url":"https://stock-news.laohu8.com/highlight/detail?id=2683636427","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683636427?lang=zh_tw&edition=fundamental","pubTime":"2026-11-14 22:47","pubTimestamp":1794667655,"startTime":"0","endTime":"0","summary":"11月14日，2026年商业健康保险创新药品目录公布，此次共有11家企业的12种药品新增纳入。调整后，2026年商业健康保险创新药品目录共有28种。《每日经济新闻》记者（以下简称每经记者）注意到，新增的创新药中，既包括本土企业研发的全球首个实体瘤CAR-T、中国首个血友病基因治疗药物等创新药，还包括多个跨国药企的创新产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://insurance.eastmoney.com/a/202611143931377614.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://insurance.eastmoney.com/a/202611143931377614.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","MEDX","06978","159992","LNGR","IBBQ","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683356586","title":"新版醫保目錄新增51個一類新藥，CAR-T首進，還有哪些亮點？","url":"https://stock-news.laohu8.com/highlight/detail?id=2683356586","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683356586?lang=zh_tw&edition=fundamental","pubTime":"2026-11-14 19:54","pubTimestamp":1794657259,"startTime":"0","endTime":"0","summary":"11月14日，2026创新药高质量发展大会在苏州举办，2026版基本医保药品目录和创新药目录（简称“双目录”）也在本次大会正式发布。尽管苏州的天气是阴沉的，大会现场气氛却十分热烈。澎湃新闻记者注意到，大会安排了超过1500个的座位，座无虚席，也有不少参会者选择站着听会。根据国家医保局发布的消息，基本医保目录新增107种药品，其中51个一类新药，再创历史新高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611143931362664.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611143931362664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4022","BK1161","ADC","MEDX","NETL","BK4230","CD","BK4080","BK4195","BK4023","PFS","BK1574","BK4116","BK4211","UCB","CAR","BK4231","LNGR","IBBQ","06978","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683636613","title":"亞盛醫藥利生妥®成功納入2026年國家醫保藥品目錄，耐立克®續約","url":"https://stock-news.laohu8.com/highlight/detail?id=2683636613","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683636613?lang=zh_tw&edition=fundamental","pubTime":"2026-11-14 18:12","pubTimestamp":1794651120,"startTime":"0","endTime":"0","summary":"截至目前，亚盛医药两款高质量全球创新药的全部获批适应症均已纳入国家医保药品目录，将为更多患者提供更加可及的创新治疗选择。利生妥于2025年7月在中国获批上市，是中国首个上市的国产原创Bcl-2抑制剂。此次利生妥成功纳入新版国家医保药品目录，将大大提升国内CLL/SLL患者的用药可及性，让更多患者能够及时获得新的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"https://www.prnasia.com/story/archive/5097943_ZH97943_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnasia.com/story/archive/5097943_ZH97943_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["06855","BK4139","AAPG","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":1,"totalSize":388,"code":"91000000","status":"200"}]}}